DMK PHARMACEUTICALS Corp Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q1 2012 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
DMK PHARMACEUTICALS Corp quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q1 2012 to Q4 2022.
  • DMK PHARMACEUTICALS Corp Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2022 was $51.5M, a 8.57% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $51.5M +$4.06M +8.57% Dec 31, 2022 10-K 2023-03-16
Q4 2021 $47.4M +$8.62M +22.2% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $38.8M +$6.18M +18.9% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $32.6M +$6.3M +23.9% Dec 31, 2019 10-K 2021-04-15
Q4 2018 $26.3M +$6.18M +30.7% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $20.1M -$2.86M -12.4% Dec 31, 2017 10-K 2019-03-15
Q4 2016 $23M +$7.51M +48.5% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $15.5M +$4.89M +46.2% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $10.6M Dec 31, 2014 10-K 2016-03-23
Q1 2014 $44.2M +$740K +1.7% Mar 31, 2014 10-KT 2015-03-26
Q1 2013 $43.5M +$2.51M +6.14% Mar 31, 2013 10-K 2014-06-23
Q1 2012 $40.9M Mar 31, 2012 10-K 2013-07-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.